With a structural long-term growth in demand for green CO2 free iron ore and a medium-term supply crisis following the risk of a cut off from Russian high grade iron ore imports to Europe, the macro and geopolitical developments, while tragic and worrisome, are clearly beneficiary to both of GRANGX’s projects. While Q1 presented some 3-6 month delays compared to previous timeline, a weaker SEK and stronger outlook for high grade iron ore and phosphate rock prices support a upwards revision of our fair value to 0.19-0.33 (0.17-0.29) in 12-24 months, which translates to SEK 95-163 post a reversed split likely to benefit trading in the share.
Magnus Brolin & Johan Widmark | 2022-05-23 12:00
Production starts unchanged despite short term delays
Q’1 2022 saw some minor delays for GRANGX’s two projects Dannemora and Apatite of some 3-6 months each. For the restart of Dannemore to produce high grade iron ore, the submission of the environmental permit application has been delayed due to long response time from the authorities at the consultations conducted in the quarter.
The Apatite project on the other hand was delayed due to technical issues at an external laboratory. With these issues resolved, the company expects to submit the environmental permit application for Dannemora later in Q2, and for the Apatite project this summer (Q3) and present the DFS for Dannemora in October. With the major financing round for these projects most likely during H1’23, we maintain our projection of production start in the Apatite project around winter ‘23/24 and production start in Dannemora around winter ‘24/25.
Significant tailwind from sanctions on Russia
As a consequence of Russia’s invasion of Ukraine and the subsequent sanctions, the European steel and iron ore industry is now under increasing pressure as more than 20% of European imports of high grade iron ore and pellets risks being cut off. This lends further support to our expectation of a continued expansion of the price premium for higher grades, such as the best in class 68% quality to be produced at Dannemora.
This emerging supply crisis can also be noticed in Sweden where resource security of supply and self-sufficiency rapidly has risen on the political agenda. Combined with the planned CO2 free production profile at Dannemora, this is likely to provide some soft support to GRANGX’s forthcoming environmental permit application.
Likewise, the war in Ukraine and subsequent trade restrictions have also affected supply of phosphate rock, which is an integral part of the vital fertilizer industry, where prices have surged from 100-150 to 250-300 USD/t. To be prudent, we only incorporate a very small part of these price changes into our valuation model, but note that it provides a very bright backdrop for the projects which will enhance both GRANGX’s chances to finance the projects at attractive levels in H1’23 as well as the chances to include some form of trade financing into the mix, should management wish to do so.
Mix of prices, FX and risk premium net positive to fair value
The aforementioned price developments and a 10% depreciation of the SEK year to date, support an upwards revision of our DCF-based fair value for the share. On the other hand, the turmoil on financial markets, with waning stock prices and rising risk premiums also affect GRANGX’s financing cost, both cost of equity and cost of debt, meaning that we’ve raised our WACC to 11,5%. All in all, this supports a very healthy financial profile, with a NPV at SEK 3.2bn and a repayment within three years. Reduced by project financing for both the Apatite project and Dannemora, where we expect debt of SEK 650m and new equity of SEK 650m, approximately SEK 1,959m remains attributable to today’s shareholders. With an estimated probability of successfully passing the next two years’ milestones of 65-85% per year, it provides support for a fair value today of around SEK 828-1,416m or SEK 0.19-0.33 per share (0.17-0.29). After the decided reversed split of 1:500 this translates to 95-163 per share.
Should the management decide to include a trade finance solution into the financing mix, this would probably cap some of the upside with regards to rising iron ore and/or phosphate rock prices, but also limit shareholder dilution and raise potential further.
GENERAL DISCLAIMER AND COPYRIGHT
This commissioned research report is for informational purposes only and is to be considered marketing communication. This research does not constitute investment advice and is not a solicitation to buy shares. Information provided here or on Emergers’ website emergers.se is not intended to be financial advice. This research shall not be construed as a recommendation or solicitation to invest in the companies described. Emergers cannot be held liable for either direct or indirect damages caused by decisions made on the basis of information in this analysis. Investors are encouraged to seek additional information as well as consult a financial advisor prior to any investment decision.
This material is not intended to be financial advice. This material has been commissioned by the Company in question and prepared and issued by Emergers, in consideration of a fee payable by the Company. Emergers standard fees are SEK 240,000 pa for the production and broad dissemination of a detailed note following by regular update notes. Fees are paid upfront in cash without recourse. Emergers may seek additional fees for the provision of roadshows and related IR services for the client but does not get remunerated for any investment banking services. We never take payment in stock, options or warrants for any of our services.
Accuracy of content: All information used in the publication of this report has been compiled from publicly available sources that are believed to be reliable, however we do not guarantee the accuracy or completeness of this report and have not sought for this information to be independently verified. Opinions contained herein represent those of the research analyst at Emergers at the time of publication. The company has been given the opportunity to influence factual statements before publication, but forecasts, conclusions and valuation reasoning are Emergers’ own. Forward-looking information or statements contain information that is based on assumptions, forecasts of future results, estimates of amounts not yet determinable, and therefore involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of their subject matter to be materially different from current expectations.
Exclusion of Liability: To the fullest extent allowed by law, Emergers shall not be liable for any direct, indirect or consequential losses, loss of profits, damages, costs or expenses incurred or suffered by you arising out or in connection with the access to, use of or reliance on any information contained in this material.
No personalised advice: The information that we provide should not be construed in any manner whatsoever as, personalised advice. Also, the information provided by us should not be construed by any subscriber or prospective subscriber as Emergers’s solicitation to effect, or attempt to effect, any transaction in a security. The securities described in this material may not be eligible for sale in all jurisdictions or to certain categories of investors. Investors are encouraged to seek additional information as well as consult a financial advisor prior to any investment decision.
Investment in securities mentioned: Emergers has a restrictive policy relating to personal dealing and conflicts of interest. Emergers does not conduct any investment business and, accordingly, does not itself hold any positions in the securities mentioned in this report. However, the respective directors, officers, employees and contractors of Emergers may have a position in any or related securities mentioned in this report, subject to Emergers’ policies on personal dealing and conflicts of interest.
Copyright: Copyright 2021 Incirrata AB (Emergers)
This document is prepared and provided by Emergers for information purposes only and should not be construed as an offer or solicitation for investment in any securities mentioned or in the topic of this document. A marketing communication under FCA Rules, this document has not been prepared in accordance with the legal requirements designed to promote the independence of investment research and is not subject to any prohibition on dealing ahead of the dissemination of investment research.
This Communication is being distributed in the United Kingdom and is directed only at (i) persons having professional experience in matters relating to investments, i.e. investment professionals within the meaning of Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, as amended (the ”FPO”) (ii) high net-worth companies, unincorporated associations or other bodies within the meaning of Article 49 of the FPO and (iii) persons to whom it is otherwise lawful to distribute it. The investment or investment activity to which this document relates is available only to such persons. It is not intended that this document be distributed or passed on, directly or indirectly, to any other class of persons and in any event and under no circumstances should persons of any other description rely on or act upon the contents of this document.
This Communication is being supplied to you solely for your information and may not be reproduced by, further distributed to or published in whole or in part by, any other person.
Emergers relies upon the ”publishers’ exclusion” from the definition of investment adviser under Section 202(a)(11) of the Investment Advisers Act of 1940 and corresponding state securities laws. This report is a bona fide publication of general and regular circulation offering impersonal investment-related advice, not tailored to a specific investment portfolio or the needs of current and/or prospective subscribers. As such, Emergers does not offer or provide personal advice and the research provided is for informational purposes only. No mention of a particular security in this report constitutes a recommendation to buy, sell or hold that or any security, or that any particular security, portfolio of securities, transaction or investment strategy is suitable for any specific person.